Krzysztof Marciniec

13PUBLICATIONS
33CO-AUTHORS
Nanotoxicology, health and safetySocial epidemiologyToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 04, 2026
Nanocarrier-Based Therapeutic Strategies in Myocardial Ischemia-Reperfusion Injury: A Systematic Review of Preclinical Evidence.

|Sep 27, 2025
Effect of Tigecycline on the Homeostasis of Human Epidermal Melanocytes and Fibroblasts.

Zuzanna Rzepka, Marta Karkoszka-Stanowska, Krzysztof Marciniec

|Mar 11, 2025
Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models.

Anna Partyka, Joanna Gołębiowska, Krzysztof Marciniec

|Feb 26, 2025
Novel Method for the Synthesis of Hydroxycobalamin[c-lactam] and Its Impact on Melanoma Cells In Vitro.

Zuzanna Rzepka, Magdalena Janus, Krzysztof Marciniec

|Sep 14, 2024
Short Communication: Novel Di- and Triselenoesters as Effective Therapeutic Agents Inhibiting Multidrug Resistance Proteins in Breast Cancer Cells.

Dominika Radomska, Robert Czarnomysy, Krzysztof Marciniec

|Aug 10, 2024
Recent Development of Fluoroquinolone Derivatives as Anticancer Agents.

Justyna Nowakowska, Dominika Radomska, Robert Czarnomysy

Pageof 3

Frequent Collaborators

3 joint publications

Elwira Chrobak

3 joint publications

Vittorio Canale

3 joint publications

Paweł Zajdel

3 joint publications

Zuzanna Rzepka